BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33144072)

  • 1. Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
    Ekeke CN; Mitchell C; Schuchert M; Dhupar R; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2021 Jan; 22(1):e132-e135. PubMed ID: 33144072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
    Rajaram R; Correa AM; Xu T; Nguyen QN; Antonoff MB; Rice D; Mehran R; Roth J; Walsh G; Swisher S; Hofstetter WL; Vaporciyan A; Cascone T; Tsao AS; Papadimitrakopoulou VA; Gandhi S; Liao Z; Sepesi B
    Clin Lung Cancer; 2020 Jul; 21(4):e294-e301. PubMed ID: 32089476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
    J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
    Mayne NR; Mallipeddi MK; Darling AJ; Jeffrey Yang CF; Eltaraboulsi WR; Shoffner AR; Naqvi IA; D'Amico TA; Berry MF
    Clin Lung Cancer; 2020 Sep; 21(5):407-414. PubMed ID: 32376115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer.
    Wang C; Wu Y; Shao J; Liu D; Li W
    BMC Cancer; 2020 Feb; 20(1):150. PubMed ID: 32093621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer.
    Maeda R; Yoshida J; Ishii G; Aokage K; Hishida T; Nishimura M; Nishiwaki Y; Nagai K
    J Thorac Oncol; 2010 Aug; 5(8):1246-50. PubMed ID: 20559152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer.
    Brown LM; Louie BE; Jackson N; Farivar AS; Aye RW; Vallières E
    Ann Thorac Surg; 2016 Oct; 102(4):1110-8. PubMed ID: 27350237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.
    Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK
    Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
    Fink-Neuboeck N; Lindenmann J; Porubsky C; Fediuk M; Anegg U; Maier A; Smolle J; Lamont E; Smolle-Juettner FM
    Clin Lung Cancer; 2020 Jul; 21(4):333-340. PubMed ID: 32273257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?
    Luzzi L; Voltolini L; Campione A; Paladini P; Ghiribelli C; Di Bisceglie M; Gotti G
    J Cardiovasc Surg (Torino); 2003 Feb; 44(1):119-23. PubMed ID: 12627083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.
    Jeon HW; Kim YD; Kim KS; Sung SW; Park HJ; Park JK
    World J Surg Oncol; 2014 Jul; 12():215. PubMed ID: 25027055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
    Khorrami M; Bera K; Leo P; Vaidya P; Patil P; Thawani R; Velu P; Rajiah P; Alilou M; Choi H; Feldman MD; Gilkeson RC; Linden P; Fu P; Pass H; Velcheti V; Madabhushi A
    Lung Cancer; 2020 Apr; 142():90-97. PubMed ID: 32120229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.